Table 1.
Patient results | Normal range | Interpretation of the tests: elevated (↑), low (↓) | |
RBC | 334 | 370–500 ×104 /µL | ↓ |
Hb | 9.1 | 11.5–15 g/dL | ↓ |
Ht | 27.6 | 34–45 % | ↓ |
Mean cell volume | 82.7 | 88–99 fL | ↓ |
Mean cell haemoglobin | 27.2 | 26–34 pg | – |
Plt | 6.7×104 | 12.5–37.5 /µL | ↓ |
D-dimer | 1.1 | 0–1 µg/mL | ↑ |
Fibrinogen | 481 | 200–400 mg/dL | ↑ |
Antithrombin Ⅲ (AT-Ⅲ) | 133 | 83–118 % | ↑ |
Fibrin Degradation Products (FDP) | 4.4 | 0–5 µg/mL | – |
Mg | 2.4 | 1.8–2.4 mg/dL | – |
Na | 132 | 138–146 mmol/L | ↓ |
K | 3.2 | 3.6–4.9 mmol/L | ↓ |
T-Bil | 1.0 | 0.3–1.2 mg/dL | – |
LDH | 673 | 119–229 U/L | ↑ |
BUN | 33 | 8–22 mg/dL | ↑ |
Cr | 2.02 | 0.4–0.7 mg/dL | ↑ |
C3 | 103 | 86–160 mg/dL | – |
C4 | 16 | 17–45 mg/dL | ↓ |
CH50 | 61 | 30–45 U/mL | ↑ |
ADAMTS13 level | 90 | 60–130 % | ↓ |
Anti-GBM Ab | 2.0> | 0–2.9 U/mL | – |
Cardiolipin IgG | 2.0> | 0–9 U/mL | – |
Anti-nuclear Ab | 40> | 0–39 U | – |
Anti-cardiolipin・β2GP1 Ab | 1.2> | 0–3.4 U/mL | – |
Direct Coomb’s test | Negative | ||
Indirect Coomb’s test | Negative |
Ab, antibodies; BUN, blood urea nitrogen; CH50, total complement activity; Cr, creatinine; Hb, haemoglobin; Ht, haematocrit; K, potassium; LDH, lactate dehydrogenase; Mg, magnesium; Na, sodium; Plt, platelets; RBC, red blood cell; T-Bil, total bilirubin.